Perspectives
"
Looking forward means playing the long game in biopharma. In a decade's time, it will all be about knowing every protein the AI way, something which will have transformed the industry, believes Viren Mehta, founding partner of Mehta Partners LLC.
" ... Read more17 Dec 2018 | From the latest Perspectives entry by Viren Mehta, Mehta Analysis: Outlook For 2029
Research Library . Recent Updates
| 27 Jul 2016 | Gilead HepC sales dynamics - where is equilibrium » |
|---|---|
| 8 Jul 2015 | Gilead - Upside to HepC franchise from currently untreated patients » |
| 21 May 2015 | Baxalta - Hemophilia franchise stable in mid term; growth possible from long acting Factor VIII » |
| 24 Apr 2015 | Roche - risk to Herceptin and Rituxan franchises » |
| 17 Mar 2015 | Breo briefing documents for Asthma » |
| 20 Feb 2015 | Novartis' LCZ696 - any cause for concern re Alzheimer's risk? » |
